Scale-up of HIV treatment through PEPFAR: A historic public health achievement

Journal of Acquired Immune Deficiency Syndromes

Volumn 60, Issue SUPPL.3, 2012, Pages

  El Sadr, Wafaa M ^a   Holmes, Charles B ^b   Mugyenyi, Peter ^c   Thirumurthy, Harsha ^d   Ellerbrock, Tedd ^e   Ferris, Robert ^f   Sanne, Ian ^g   Asiimwe, Anita ^h   Hirnschall, Gottfried ⁱ   Nkambule, Rejoice N ^j   Stabinski, Lara ^b   Affrunti, Megan ^a   Teasdale, Chloe ^a   Zulu, Isaac ^e   Whiteside, Alan ^k  

^a Mailman School of Public Health ^*  (United States)

^b Office of the US Global AIDS Coordinator   (United States)

^c JOINT CLINICAL RESEARCH CENTRE   (Uganda)

^d IL   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

^g UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^h RWANDA BIOMEDICAL CENTER   (Rwanda)

ⁱ WORLD HEALTH ORGANIZATION   (Switzerland)

^j Ministry of Health   (Swaziland)

^k UNIVERSITY OF KWAZULU NATAL   (South Africa)

more..

Author keywords

[No Author keywords available]

Indexed keywords

STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ARTICLE; EARTHQUAKE; EMERGENCY HEALTH SERVICE; FEASIBILITY STUDY; HEALTH CARE; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORBIDITY; MORTALITY; ORGANIZATION AND MANAGEMENT; PATIENT COMPLIANCE; PREDICTION; PRESIDENT EMERGENCY PLAN FOR AIDS RELIEF; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SCALE UP; SOCIOECONOMICS; VIOLENCE;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMMUNICABLE DISEASE CONTROL; DISEASE TRANSMISSION, INFECTIOUS; DRUG UTILIZATION; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; MALE; NATIONAL HEALTH PROGRAMS; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; UNITED STATES; WORLD HEALTH;

EID: 84866103737     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31825eb27b     Document Type: Article

References (55)

1. WHO. Global HIV/AIDS Response: Epidemic Update and Health Sector Progress Towards Universal Access. Geneva, Switzerland: HIV/AIDS Department, World Health Organization; 2011.
2. PEPFAR. Using Science to Save Lives: Latest PEPFAR Results. 2011. Available at: http://www.pepfar.gov/documents/organization/187770.pdf. Accessed June 19, 2012.
3. Dybul M. Lessons learned from PEPFAR. J Acquir Immune Defic Syndr. 2009;52(suppl 1):S12-S13.
4. PEPFAR. Five year partnership framework in support of the Tanzanian national response to HIV and AIDS, 2009-2012 between the government of the United Republic of Tanzania and the Government of the United States of America. Available at: http://www.pepfar.gov/frameworks/tanzania/139369.htm. Accessed: June 19, 2012.
5. Office of the US Global AIDS Coordinator. PEPFAR: Making smart investments to increase impact and efficiency and save more lives. Available at: http://www.pepfar.gov/documents/organization/176783.pdf. Accessed June 19, 2012.
6. WHO. Task Shifting: Global Recommendations and Guidelines. Geneva, Switzerland: WHO; 2008.
7. Holmes CB, Coggin W, Jamieson D, et al. Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs. JAMA. 2010;304:313-320.
8. Jaffar S, Amuron B, Foster S, et al. Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet. 2009;374:2080-2089.
9. Veenstra N, Whiteside A, Lalloo D, et al. Unplanned antiretroviral treatment interruptions in southern Africa: how should we be managing these? Global Health. 2010;6:4.
10. O'Connor C, Osih R, Jaffer A. Loss to follow-up of stable antiretroviral therapy patients in a decentralized down-referral model of care in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2011;58:429-432.
11. Chung J, O'Brien M, Price J, et al. Quantification of physician-time saved in a task shifting pilot program in Rwanda. Presented at: XVII International AIDS Conference, August 6, 2008. Vol Abstract #: WEAB0205, 2008; Mexico City, Mexico.
12. Torpey KE, Kabaso ME, Mutale LN, et al. Adherence support workers: a way to address human resource constraints in antiretroviral treatment programs in the public health setting in Zambia. PLoS One. 2008;3:e2204.
13. Shumbusho F, van Griensven J, Lowrance D, et al. Task shifting for scale-up of HIV care: evaluation of nurse-centered antiretroviral treatment at rural health centers in Rwanda. PLoS Med. 2009;6:e1000163.
14. Callaghan M, Ford N, Schneider H. A systematic review of task-shifting for HIV treatment and care in Africa. Hum Resour Health. 2010;8:8.
15. Veenstra N, Whiteside A. Economic impact of HIV. Best Pract Res Clin Obstet Gynaecol. 2005;19:197-210.
16. Sanne I, Orrell C, Fox MP, et al. Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial. Lancet. 2010;376:33-40.
17. Long L, Brennan A, Fox MP, et al. Treatment outcomes and costeffectiveness of shifting management of stable ART patients to nurses in South Africa: an observational cohort. PLoS Med. 2011;8:e1001055.
18. Brennan A, Long L, Maskew M, et al. Outcomes of stable HIV-positive patients down-referred from doctor-managed ART clinics to nursemanaged primary health clinics for monitoring and treatment. AIDS. 2011;25:2027-2036.
19. Philips M, Zachariah R, Venis S. Task shifting for antiretroviral treatment delivery in sub-Saharan Africa: not a panacea. Lancet. 2008;371:682-684.
20. Menzies NA, Berruti AA, Berzon R, et al. The cost of providing comprehensive HIV treatment in PEPFAR-supported programs. AIDS. 2011;25:1753-1760.
21. Jamieson D. Efficiency gains through smarter transportation and pooled procurement. Available at: http://www.pepfar.gov/documents/organization/158512. pdf. Accessed March 1, 2012.
22. Right to Care. Right to Care Annual Report 2010. Johannesburg, South Africa; 2010.
23. The AIDS Support Organization Web site. Available at: http://www.tasouganda.org/. Accessed June 20, 2012.
24. Joint Clinical Research Centre Web site. Available at: http://www.jcrc.org.ug/. Accessed June 20, 2012.
25. Pape JW, Rouzier V, Ford H, et al. The GHESKIO field hospital and clinics after the earthquake in Haiti-dispatch 3 from Port-au-Prince. N Engl J Med. 2010;362:e34.
26. Joint United Nations Program on HIV/AIDS (UNAIDS). Global Report: UNAIDS Report on the Global AIDS Epidemic. Geneva, Switzerland: UNAIDS; 2010.
27. Nash D, Elul B, Rabkin M, et al. Strategies for more effective monitoring and evaluation systems in HIV programmatic scale-up in resourcelimited settings: implications for health systems strengthening. J Acquir Immune Defic Syndr. 2009;52(suppl 1):S58-S62.
28. Auld AF, Mbofana F, Shiraishi RW, et al. Four-year treatment outcomes of adult patients enrolled in Mozambique's rapidly expanding antiretroviral therapy program. PLoS One. 2011;6:e18453.
29. Bendavid E, Holmes C, Miller G. HIV international assistance and adult mortality: Africa. Presented at: Conference on the Retroviruses and Opportunistic Infections, abstract 5, March 7, 2012; Seattle, WA
30. Bendavid E, Bhattacharya J. The President's Emergency Plan for AIDS Relief in Africa: an evaluation of outcomes. Ann Intern Med. 2009;150:688-695.
31. Kiboneka A, Nyatia RJ, Nabiryo C, et al. Combination antiretroviral therapy in population affected by conflict: outcomes from large cohort in northern Uganda. BMJ. 2009;338:b201.
32. El-Sadr WM, Lundgren JD, Neaton JD, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355:2283-2296.
33. DART Trial Team. Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts, 200 cells/microl. AIDS. 2008;22:237-247.
34. Kenya. UNGASSoHAUCR. 2010.
35. Vreeman RC, Nyandiko WM, Sang E, et al. Impact of the Kenya postelection crisis on clinic attendance and medication adherence for HIVinfected children in western Kenya. Confl Health. 2009;3:5.
36. Yoder RB, Nyandiko WM, Vreeman RC, et al. Long-term impact of the Kenya postelection crisis on clinic attendance and medication adherence for HIV-infected children in western Kenya. J Acquir Immune Defic Syndr. 2012;59:199-206.
37. PEPFAR. Partnership to Fight HIV/AIDS in Cote d'Ivoire. Available at: http://www.pepfar.gov/countries/cotedivoire/index.htm. Accessed June 20, 2012.
38. Goosby E. US Department of State. An update on PEPFAR in Cote d'Ivoire. Available at: http://blogs.state.gov/index.php/site/entry/pepfar-cote-divoire.
39. USAID. Haiti, HIV/AIDS and PEPFAR. Available at: http://haiti.usaid. gov/issues/hiv-aids.php. Accessed June 20, 2012.
40. Goosby E. Building of What Works: U. S. HIV/AIDS Programs Forge Haiti Earthquake Response. US Department of State. 2011. Available at: http://blogs.state.gov/index.php/site/entry/u.s.-hiv-aids-programs-haiti- earthquake.
41. UN Security Council. UN Security Council Resolution 1308 (2000) on the Responsibility of the Security Council in the Maintenance of International Peace and Security: HIV/AIDS and International Peace-keeping Operations. New York, NY: United Nations; 2000.
42. de Waal A, Klot JF, Mahajan M, with Dana Huber and ASCI co-chairs Georg Frerks and Souleymane M'Boup. HIV/AIDS, Security and Conflict: New Realities, New Responses, AIDS', Security and Conflict Initiative. New York, NY: Social Science Research Council and Netherlands Institute of International Relations; 2010.
43. Regondi I, Whiteside A. Global development goals and the international HIV response: A chance for renewal. In: Wilkinson R, Hulme D, ed. The Millenium Development Goals and Beyond; Global Development after 2015. London and New York: Routledge; 2012.
44. Fox MP, Rosen S, MacLeod WB, et al. The impact of HIV/AIDS on labour productivity in Kenya. Trop Med Int Health. 2004;9:318-324.
45. Thirumurthy H, Zivin JG, Goldstein M. The economic impact of AIDS treatment: labor supply in Western Kenya. J Hum Resour. 2008;43:511-552.
46. Larson BA, Fox MP, Rosen S, et al. Early effects of antiretroviral therapy on work performance: preliminary results from a cohort study of Kenyan agricultural workers. AIDS. 2008;22:421-425.
47. Beard J, Feeley F, Rosen S. Economic and quality of life outcomes of antiretroviral therapy for HIV/AIDS in developing countries: a systematic literature review. AIDS Care. 2009;21:1343-1356.
48. Rosen S, Larson B, Brennan A, et al. Economic outcomes of patients receiving antiretroviral therapy for HIV/AIDS in South Africa are sustained through three years on treatment. PLoS One. 2010;5:e12731.
49. Thirumurthy H, Jafri A, Srinivas G, et al. Two-year impacts on employment and income among adults receiving antiretroviral therapy in Tamil Nadu, India: a cohort study. AIDS. 2011;25:239-246.
50. Zivin JG, Thirumurthy H, Goldstein M. AIDS treatment and intrahousehold resource allocation: children's nutrition and schooling in Kenya. J Public Econ. 2009;93:1008-1015.
51. Severe P, Juste MA, Ambroise A, et al. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med. 2010;363:257-265.
52. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505.
53. Schwartlander B, Stover J, Hallett T, et al. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet. 2011;377:2031-2041.
54. Hermans S, van Leth F, Manabe Y, et al. Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study. HIV Med. 2012;13:337-344.
55. Resch S, Korenromp E, Stover J, et al. Economic returns to investment in AIDS treatment in low and middle income countries. PLoS One. 2011;6:e25310.